| pubmed-article:8817393 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8817393 | lifeskim:mentions | umls-concept:C0242767 | lld:lifeskim |
| pubmed-article:8817393 | lifeskim:mentions | umls-concept:C0038250 | lld:lifeskim |
| pubmed-article:8817393 | lifeskim:mentions | umls-concept:C1186763 | lld:lifeskim |
| pubmed-article:8817393 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:8817393 | lifeskim:mentions | umls-concept:C0079611 | lld:lifeskim |
| pubmed-article:8817393 | lifeskim:mentions | umls-concept:C1332710 | lld:lifeskim |
| pubmed-article:8817393 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:8817393 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8817393 | pubmed:dateCreated | 1996-12-12 | lld:pubmed |
| pubmed-article:8817393 | pubmed:abstractText | A murine monoclonal antibody with specificity for the CD34 antigen has been produced and designated BIRMA-K3. The antibody characterized as IgG1(kappa) has been shown to react with KG-1a cells following treatment of the cells with glycoprotease enzyme, indicating reactivity with the class III epitope of CD34. It was possible to show that class I and class II anti-CD34 antibodies were not able to inhibit binding of BIRMA-K3. Investigation of FITC-labeled as well as PE-labeled BIRMA-K3 resulted in a clear cut-off staining of acute leukemias and CD34+ cell counts in patients submitted to high-dose chemotherapy and stem cell transplantation. The results obtained correlate strongly with those from HPCA-2, the Becton-Dickinson class III antibody. | lld:pubmed |
| pubmed-article:8817393 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8817393 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8817393 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8817393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8817393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8817393 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8817393 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8817393 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:8817393 | pubmed:issn | 1061-6128 | lld:pubmed |
| pubmed-article:8817393 | pubmed:author | pubmed-author:LoweJ AJA | lld:pubmed |
| pubmed-article:8817393 | pubmed:author | pubmed-author:McDonaldD FDF | lld:pubmed |
| pubmed-article:8817393 | pubmed:author | pubmed-author:HöffkesH GHG | lld:pubmed |
| pubmed-article:8817393 | pubmed:author | pubmed-author:PedersenR ORO | lld:pubmed |
| pubmed-article:8817393 | pubmed:author | pubmed-author:SchmidkteGG | lld:pubmed |
| pubmed-article:8817393 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8817393 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:8817393 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8817393 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8817393 | pubmed:pagination | 261-70 | lld:pubmed |
| pubmed-article:8817393 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:meshHeading | pubmed-meshheading:8817393-... | lld:pubmed |
| pubmed-article:8817393 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8817393 | pubmed:articleTitle | BIRMA-K3, a new monoclonal antibody for CD34 immunophenotyping and stem and progenitor cell assay. | lld:pubmed |
| pubmed-article:8817393 | pubmed:affiliation | Department of Medicine, Otto-von-Guericke University of Magdeburg, Germany. | lld:pubmed |
| pubmed-article:8817393 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8817393 | pubmed:publicationType | Comparative Study | lld:pubmed |
